UTHR United Therapeutics Corporation
Fundamentals / CIK 0001082554 / USDUnited Therapeutics Corporation reported $3.19B in revenue and net income of $1.23B for the trailing twelve months ended September 30, 2026 (up 4.1% year over year), with a 86.3% gross margin and a 41.4% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open UTHR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$3.19B +4.1% YoY
-
Operating Income TTM$1.32B 41.4% margin
-
Net Income TTM$1.23B 38.6% net margin
-
Diluted EPS TTM$27.17 Split-adjusted
-
Free Cash Flow TTM$867.2M 27.2% FCF margin
-
Cash & ST Investments Sep 30, 2026$2.07B Total debt: --
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.18B | $2.88B | $2.33B | $1.94B | $1.69B | $1.48B | $1.45B | $1.63B | $1.73B | $1.60B |
| Cost of Revenue | $384.4M | $309.7M | $257.5M | $151.6M | $122.5M | $108.1M | $117.6M | $198.7M | $105.7M | $72.70M |
| Gross Profit | $2.80B | $2.57B | $2.07B | $1.78B | $1.56B | $1.38B | $1.33B | $1.43B | $1.62B | $1.53B |
| Research & Development | $550.0M | $481.0M | $408.0M | $322.9M | $540.1M | $357.7M | $1.18B | $357.9M | $264.6M | $147.6M |
| Selling, General & Admin | $755.8M | $709.7M | $477.1M | $482.1M | $467.0M | -- | -- | $265.8M | $330.1M | $316.8M |
| Operating Income | $1.49B | $1.38B | $1.18B | $979.7M | $555.9M | $593.6M | -$187.6M | $805.4M | $814.9M | $1.06B |
| EBITDA | $1.58B | $1.45B | $1.24B | $1.03B | $605.8M | $643.5M | -$141.7M | $841.3M | $845.9M | $1.09B |
| Interest Income | $192.0M | $199.1M | $162.7M | $45.20M | $16.70M | $28.60M | $44.20M | $28.60M | $10.90M | $3.50M |
| Interest Expense | $19.50M | $42.90M | $59.30M | $32.40M | $18.60M | $23.50M | $44.20M | $13.90M | $9.00M | $3.90M |
| Income Before Tax | $1.71B | $1.54B | $1.27B | $950.6M | $593.9M | $638.9M | -$165.0M | $758.9M | $769.5M | $1.06B |
| Income Tax Expense | $379.2M | $343.9M | $289.5M | $223.3M | $118.1M | $124.1M | -$60.50M | $169.7M | $351.6M | $346.5M |
| Net Income | $1.33B | $1.20B | $984.8M | $727.3M | $475.8M | $514.8M | -$104.5M | $589.2M | $417.9M | $713.7M |
| Basic EPS | $30.13 | $26.44 | $21.04 | $15.98 | $10.60 | $11.65 | -$2.39 | $13.54 | $9.50 | $16.29 |
| Diluted EPS | $27.86 | $24.64 | $19.81 | $15.00 | $10.06 | $11.54 | -$2.39 | $13.39 | $9.31 | $15.25 |
| Basic Shares Outstanding | 44.3M | 45.2M | 46.8M | 45.5M | 44.9M | 44.2M | 43.8M | 43.5M | 44.0M | 43.8M |
| Diluted Shares Outstanding | 47.9M | 48.5M | 49.7M | 48.5M | 47.3M | 44.6M | 43.8M | 44.0M | 44.9M | 46.8M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $832.5M | $783.3M | $781.5M | $790.2M | $799.5M | $798.6M | $794.4M | $735.9M |
| Cost of Revenue | $99.10M | $99.50M | $133.4M | $103.4M | $100.9M | $87.60M | $92.50M | $75.90M |
| Gross Profit | $733.4M | $683.8M | $648.1M | $686.8M | $698.6M | $711.0M | $701.9M | $660.0M |
| Research & Development | $279.2M | $146.3M | $138.2M | $139.5M | $127.5M | $134.0M | $149.0M | $133.8M |
| Selling, General & Admin | $146.4M | $206.7M | $184.1M | $190.6M | $182.6M | $212.5M | $170.1M | $168.5M |
| Operating Income | $307.8M | $330.8M | $325.8M | $356.7M | $388.5M | $364.5M | $382.8M | $357.7M |
| EBITDA | $334.2M | $355.0M | $348.4M | $379.5M | $410.4M | $385.6M | $402.6M | $377.4M |
| Interest Income | $33.70M | $31.50M | $41.80M | $43.20M | $46.40M | $51.30M | $51.10M | $49.30M |
| Interest Expense | $2.90M | $2.90M | $3.00M | $3.10M | $3.00M | $7.30M | $6.10M | $7.90M |
| Income Before Tax | $372.8M | $372.7M | $318.3M | $444.0M | $438.0M | $408.4M | $423.5M | $396.5M |
| Income Tax Expense | $114.2M | $39.70M | $43.40M | $79.70M | $99.30M | $98.90M | $101.3M | $95.20M |
| Net Income | $258.6M | $333.0M | $274.9M | $364.3M | $338.7M | $309.5M | $322.2M | $301.3M |
| Basic EPS | $6.06 | $7.82 | $6.32 | -- | $7.73 | $6.86 | $7.18 | -- |
| Diluted EPS | $5.71 | $7.27 | $5.82 | -- | $7.16 | $6.41 | $6.63 | -- |
| Basic Shares Outstanding | 42.7M | 42.6M | 43.5M | -- | 43.8M | 45.1M | 44.9M | -- |
| Diluted Shares Outstanding | 45.3M | 45.8M | 47.2M | -- | 47.3M | 48.3M | 48.6M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $1.56B | $1.70B | $1.21B | $961.2M | $894.8M | $738.7M | $738.4M | $669.2M | $705.1M | $1.02B |
| Short-Term Investments | $1.36B | $1.57B | $1.79B | $1.88B | $1.04B | $1.10B | $747.5M | $746.7M | $222.3M | $27.80M |
| Cash & Short-Term Investments | $2.92B | $3.27B | $2.99B | $2.84B | $1.93B | $1.83B | $1.49B | $1.42B | $927.4M | $1.05B |
| Accounts Receivable, Net | $350.2M | $279.3M | $278.9M | $220.4M | $198.7M | $157.4M | $151.4M | $175.7M | $297.1M | $214.5M |
| Inventory | $183.1M | $157.9M | $111.8M | $102.0M | $93.80M | $86.50M | $93.40M | $101.0M | $107.9M | $100.0M |
| Other Current Assets | $248.9M | $169.7M | $166.2M | $219.2M | $100.4M | $88.30M | $133.8M | $75.40M | $115.5M | $59.50M |
| Total Current Assets | $3.70B | $3.87B | $3.55B | $3.38B | $2.32B | $2.17B | $1.86B | $1.77B | $1.45B | $1.42B |
| Property, Plant & Equipment, Net | $1.73B | $1.22B | $1.05B | $861.5M | $780.9M | $731.6M | $738.5M | $699.7M | $545.7M | $489.3M |
| Goodwill | $32.30M | $32.30M | $33.70M | $28.00M | $28.00M | $28.00M | $28.00M | $31.50M | $13.70M | $10.30M |
| Long-Term Investments | $1.78B | $1.48B | $1.91B | $1.32B | $1.65B | $1.15B | $767.5M | $442.6M | $502.7M | $2.30M |
| Other Non-Current Assets | $196.9M | $222.1M | $151.8M | $114.3M | $108.2M | $169.9M | $154.6M | $224.2M | $224.1M | $197.1M |
| Total Non-Current Assets | $4.18B | $3.49B | $3.62B | $2.66B | $2.85B | $2.45B | $2.05B | $1.63B | $1.43B | $900.8M |
| Total Assets | $7.88B | $7.36B | $7.17B | $6.04B | $5.17B | $4.62B | $3.91B | $3.40B | $2.88B | $2.33B |
| Accounts Payable | $7.10M | $6.00M | $5.60M | $4.10M | $3.80M | $4.10M | $9.90M | $23.10M | $8.40M | $8.10M |
| Other Current Liabilities | $72.60M | $93.60M | $71.00M | $32.50M | $28.40M | $39.50M | $39.60M | $38.30M | $33.50M | $33.50M |
| Total Current Liabilities | $560.6M | $738.1M | $804.4M | $343.2M | $305.4M | $323.3M | $463.0M | $276.6M | $444.7M | $332.5M |
| Other Non-Current Liabilities | $223.2M | $181.9M | $77.80M | $104.6M | $104.8M | $96.50M | $70.00M | $66.60M | $63.70M | $130.9M |
| Total Non-Current Liabilities | $223.2M | $181.9M | $377.8M | $904.6M | $904.8M | $896.5M | $670.0M | $316.6M | $313.7M | $130.9M |
| Total Liabilities | $783.8M | $920.0M | $1.18B | $1.25B | $1.21B | $1.22B | $1.13B | $593.2M | $758.4M | $463.4M |
| Total Debt (incl. Leases) | -- | -- | -- | -- | -- | -- | $4.80M | -- | -- | -- |
| Common Stock | $800K | $800K | $700K | $700K | $700K | $700K | $700K | $700K | $700K | $700K |
| Retained Earnings | $8.56B | $7.22B | $6.03B | $5.04B | $4.32B | $3.84B | $3.33B | $3.43B | $2.85B | $2.43B |
| Accumulated Other Comp. Income | $900K | -$3.40M | -$12.80M | -$55.50M | -$23.00M | -$14.20M | -$14.20M | -$7.90M | -$19.60M | -$16.80M |
| Total Stockholders' Equity | $7.10B | $6.44B | $5.98B | $4.80B | $3.96B | $3.40B | $2.78B | $2.79B | $2.10B | $1.85B |
| Total Equity | $7.10B | $6.44B | $5.98B | $4.80B | $3.96B | $3.40B | $2.78B | $2.79B | $2.10B | $1.85B |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $1.19B | $1.80B | $1.28B | $1.56B | $1.34B | $1.59B | $1.90B | $1.70B |
| Short-Term Investments | $879.0M | $859.1M | $874.0M | $1.36B | $1.43B | $1.46B | $1.42B | $1.57B |
| Cash & Short-Term Investments | $2.07B | $2.66B | $2.15B | $2.92B | $2.77B | $3.05B | $3.32B | $3.27B |
| Accounts Receivable, Net | $348.6M | $310.3M | $312.0M | $350.2M | $297.7M | $379.3M | $322.0M | $279.3M |
| Inventory | $201.9M | $193.8M | $178.3M | $183.1M | $176.5M | $169.2M | $165.4M | $157.9M |
| Other Current Assets | $261.8M | $317.3M | $228.0M | $248.9M | $252.2M | $229.7M | $131.1M | $169.7M |
| Total Current Assets | $2.88B | $3.48B | $2.87B | $3.70B | $3.49B | $3.83B | $3.94B | $3.87B |
| Property, Plant & Equipment, Net | $2.04B | $1.93B | $1.84B | $1.73B | $1.56B | $1.36B | $1.30B | $1.22B |
| Goodwill | -- | -- | -- | $32.30M | -- | -- | -- | $32.30M |
| Long-Term Investments | $1.47B | $1.14B | $1.32B | $1.78B | $1.57B | $1.92B | $1.71B | $1.48B |
| Other Non-Current Assets | $259.4M | $239.5M | $233.2M | $196.9M | $262.6M | $233.3M | $222.4M | $222.1M |
| Total Non-Current Assets | $4.15B | $3.74B | $3.84B | $4.18B | $3.86B | $4.08B | $3.80B | $3.49B |
| Total Assets | $7.03B | $7.22B | $6.71B | $7.88B | $7.35B | $7.91B | $7.74B | $7.36B |
| Accounts Payable | -- | -- | -- | $7.10M | -- | -- | -- | $6.00M |
| Other Current Liabilities | $104.1M | $110.0M | $100.8M | $72.60M | $78.30M | $95.10M | $154.5M | $93.60M |
| Total Current Liabilities | $624.3M | $607.8M | $599.1M | $560.6M | $546.3M | $527.1M | $721.5M | $738.1M |
| Other Non-Current Liabilities | $133.8M | $212.0M | $214.0M | $223.2M | $214.6M | $207.3M | $215.2M | $181.9M |
| Total Non-Current Liabilities | $133.8M | $212.0M | $214.0M | $223.2M | $214.6M | $207.3M | $215.2M | $181.9M |
| Total Liabilities | $758.1M | $819.8M | $813.1M | $783.8M | $760.9M | $734.4M | $936.7M | $920.0M |
| Common Stock | $800K | $800K | $800K | $800K | $800K | $800K | $800K | $800K |
| Retained Earnings | $9.42B | $9.16B | $8.83B | $8.56B | $8.19B | $7.85B | $7.54B | $7.22B |
| Accumulated Other Comp. Income | -$30.30M | -$16.20M | -$10.20M | $900K | $100K | $0 | -$1.20M | -$3.40M |
| Total Stockholders' Equity | $6.28B | $6.40B | $5.90B | $7.10B | $6.59B | $7.17B | $6.81B | $6.44B |
| Total Equity | $6.28B | $6.40B | $5.90B | $7.10B | $6.59B | $7.17B | $6.81B | $6.44B |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $1.33B | $1.20B | $984.8M | $727.3M | $475.8M | -- | -$104.5M | $589.2M | $417.9M | $713.7M |
| Depreciation & Amortization | $85.60M | $72.50M | $53.20M | $51.30M | $49.90M | $49.90M | $45.90M | $35.90M | $31.00M | $31.60M |
| Stock-Based Compensation | $147.7M | $144.0M | $39.10M | $106.8M | $138.5M | $163.8M | $45.40M | -$26.40M | $73.50M | $12.10M |
| Change in Receivables | -$70.90M | -$400K | -$58.50M | -$21.70M | -$41.30M | -$6.00M | $24.40M | $121.4M | -$82.70M | -$21.70M |
| Change in Inventory | -$52.60M | -$46.90M | -$13.60M | -$13.40M | -$7.50M | $10.30M | $12.90M | $9.30M | -$500K | -$24.50M |
| Operating Cash Flow | $1.56B | $1.33B | $978.0M | $802.5M | $598.2M | $755.7M | -$206.6M | $778.4M | $474.2M | $643.6M |
| Capital Expenditure | -$520.5M | -$246.5M | -$230.4M | -$138.8M | -$120.8M | -$59.30M | -$83.70M | -$184.4M | -$86.30M | -$38.00M |
| Free Cash Flow | $1.04B | $1.08B | $747.6M | $663.7M | $477.4M | $696.4M | -$290.3M | $594.0M | $387.9M | $605.6M |
| Acquisitions, Net | $0 | $0 | -$89.20M | $0 | $0 | $0 | $0 | -$124.1M | -- | -$5.20M |
| Purchases of Investments | -$3.41B | -$1.65B | -$2.51B | -$1.71B | -$1.90B | -$2.31B | -$1.27B | -$762.7M | -$718.4M | -$36.00M |
| Sales & Maturities of Investments | $3.45B | $2.37B | $2.14B | $1.02B | $1.42B | $1.60B | $980.1M | $312.3M | -- | -- |
| Investing Cash Flow | -$551.3M | $417.2M | -$719.6M | -$811.5M | -$486.9M | -$738.5M | -$335.4M | -$820.6M | -$835.6M | $48.30M |
| Share Repurchases | -$1.00B | -$1.00B | $0 | $0 | -- | -- | -- | -- | -$250.0M | -$500.0M |
| Financing Cash Flow | -$1.15B | -$1.25B | -$11.90M | $75.40M | $44.80M | -$16.90M | $611.2M | $6.30M | $43.30M | -$497.7M |
| Net Change in Cash | -$140.1M | $489.5M | $246.5M | $66.40M | $156.1M | $300K | $69.20M | -$35.90M | -$317.9M | $191.2M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $258.6M | $333.0M | $274.9M | $364.3M | $338.7M | $309.5M | $322.2M | $301.3M |
| Depreciation & Amortization | $26.40M | $24.20M | $22.60M | $22.80M | $21.90M | $21.10M | $19.80M | $19.70M |
| Stock-Based Compensation | $41.00M | $43.40M | $33.90M | $39.00M | $39.10M | $37.80M | $31.80M | $27.00M |
| Change in Receivables | -$38.30M | $1.70M | $38.20M | -$52.50M | $81.60M | -$57.30M | -$42.70M | $62.50M |
| Change in Inventory | -$25.60M | -$17.70M | -$40.10M | -$16.50M | -$17.50M | -$7.40M | -$11.20M | -$11.60M |
| Operating Cash Flow | $306.5M | $313.6M | $463.3M | $346.2M | $562.1M | $191.7M | $461.2M | $341.2M |
| Capital Expenditure | -$180.7M | -$108.0M | -$100.8M | -$172.9M | -$210.5M | -$62.20M | -$74.90M | -$86.70M |
| Free Cash Flow | $125.8M | $205.6M | $362.5M | $173.3M | $351.6M | $129.5M | $386.3M | $254.5M |
| Purchases of Investments | -$558.9M | -$69.10M | -$701.7M | -$520.3M | -$385.9M | -$1.81B | -$692.3M | -$478.5M |
| Sales & Maturities of Investments | $213.1M | $265.3M | $1.58B | $485.5M | $778.5M | $1.57B | $611.7M | $478.0M |
| Investing Cash Flow | -$510.6M | $87.50M | $743.7M | -$227.6M | $140.9M | -$299.9M | -$164.7M | -$123.2M |
| Share Repurchases | -$500.0M | $0 | -$1.50B | $0 | -$1.00B | $0 | $0 | $0 |
| Financing Cash Flow | -$410.2M | $122.4M | -$1.48B | $98.40M | -$956.0M | -$198.6M | -$93.80M | -$74.70M |
| Net Change in Cash | -$614.3M | $523.5M | -$277.4M | $217.0M | -$253.0M | -$306.8M | $202.7M | $143.3M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 87.9% | 89.2% | 88.9% | 92.2% | 92.7% | 92.7% | 91.9% | 87.8% | 93.9% | 95.5% |
| Operating Margin | 46.9% | 47.9% | 50.9% | 50.6% | 33.0% | 40.0% | -12.9% | 49.5% | 47.2% | 66.4% |
| Net Profit Margin | 41.9% | 41.5% | 42.3% | 37.6% | 28.2% | 34.7% | -7.2% | 36.2% | 24.2% | 44.6% |
| Return on Equity (ROE) | 18.8% | 18.5% | 16.5% | 15.2% | 12.0% | 15.2% | -3.8% | 21.1% | 19.9% | 38.6% |
| Return on Assets (ROA) | 16.9% | 16.2% | 13.7% | 12.0% | 9.2% | 11.2% | -2.7% | 17.3% | 14.5% | 30.7% |
| Current Ratio | 6.60x | 5.25x | 4.41x | 9.85x | 7.61x | 6.70x | 4.03x | 6.39x | 3.26x | 4.29x |
| Quick Ratio | 6.28x | 5.03x | 4.28x | 9.55x | 7.30x | 6.44x | 3.83x | 6.03x | 3.01x | 3.98x |
| Debt to Equity | -- | -- | -- | -- | -- | -- | 0.00x | -- | -- | -- |
| Revenue Growth (YoY) | +10.6% | +23.6% | +20.2% | +14.9% | +13.6% | +2.4% | -11.0% | -5.7% | +7.9% | +9.1% |
| Gross Profit Growth (YoY) | +9.0% | +24.0% | +16.0% | +14.2% | +13.7% | +3.3% | -6.9% | -11.8% | +6.1% | +9.3% |
| Operating Income Growth (YoY) | +8.4% | +16.2% | +20.9% | +76.2% | -6.4% | -- | -123.3% | -1.2% | -23.2% | +51.9% |
| Net Income Growth (YoY) | +11.7% | +21.4% | +35.4% | +52.9% | -7.6% | -- | -117.7% | +41.0% | -41.4% | +9.5% |
| EPS Growth (YoY) | +14.0% | +25.7% | +31.7% | +50.8% | -9.0% | -- | -117.7% | +42.5% | -41.7% | +15.0% |
| Operating Cash Flow Growth (YoY) | +17.6% | +35.7% | +21.9% | +34.2% | -20.8% | -- | -126.5% | +64.2% | -26.3% | +68.1% |
| Free Cash Flow Growth (YoY) | -3.7% | +44.5% | +12.6% | +39.0% | -31.4% | -- | -148.9% | +53.1% | -35.9% | +81.9% |
| 5Y Revenue / Share Growth | +114.1% | +92.5% | +32.9% | +8.5% | +2.8% | +5.3% | +23.7% | +67.8% | +123.0% | +180.8% |
| 10Y Revenue / Share Growth | +125.5% | +138.1% | +123.0% | +142.0% | +188.7% | +217.8% | +391.4% | +508.9% | -- | -- |
| 5Y Net Income / Share Growth | +158.7% | -- | +55.4% | +68.3% | -35.0% | -17.8% | -133.8% | +288.6% | +62.5% | +327.5% |
| 10Y Net Income / Share Growth | +112.7% | +274.7% | +503.7% | +173.5% | +178.0% | +517.4% | -753.6% | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 86.3% | 86.1% | 86.6% | 87.9% | 88.6% | 89.0% | 89.0% | 89.2% |
| Operating Margin | 41.4% | 44.4% | 45.3% | 46.9% | 47.7% | 47.0% | 46.9% | 47.9% |
| Net Profit Margin | 38.6% | 41.6% | 40.6% | 41.9% | 40.7% | 40.4% | 40.4% | 41.5% |
| Return on Equity (ROE) | 19.6% | 20.5% | 21.8% | 18.8% | 19.3% | 17.3% | 17.8% | 18.5% |
| Return on Assets (ROA) | 17.5% | 18.2% | 19.2% | 16.9% | 17.3% | 15.7% | 15.6% | 16.2% |
| Current Ratio | 4.61x | 5.73x | 4.79x | 6.60x | 6.40x | 7.26x | 5.46x | 5.25x |
| Quick Ratio | 4.29x | 5.41x | 4.50x | 6.28x | 6.07x | 6.94x | 5.23x | 5.03x |
| Revenue Growth (YoY) | +4.1% | -1.9% | -1.6% | +7.4% | +6.8% | +11.7% | +17.2% | +19.7% |
| Gross Profit Growth (YoY) | +5.0% | -3.8% | -7.7% | +4.1% | +4.9% | +11.6% | +16.1% | +21.4% |
| Operating Income Growth (YoY) | -20.8% | -9.2% | -14.9% | -0.3% | +13.2% | +13.9% | +7.4% | +37.5% |
| Net Income Growth (YoY) | -23.6% | +7.6% | -14.7% | +20.9% | +9.6% | +11.3% | +5.1% | +38.8% |
| EPS Growth (YoY) | -21.6% | +14.0% | -12.0% | -- | +11.5% | +9.6% | +10.1% | -- |
| Operating Cash Flow Growth (YoY) | -45.5% | +63.6% | +0.5% | +1.5% | +49.0% | -17.4% | +22.5% | +126.4% |
| Free Cash Flow Growth (YoY) | -64.2% | +58.8% | -6.2% | -31.9% | +16.9% | -30.8% | +14.2% | +253.5% |